Prepping for FDA approval, Grail is partnering with health systems to validate its pan-cancer test

Grail, a company focused on early cancer detection, introduced its test that screens for more than 50 kinds of cancer last year. At AWS’ Thursday conference for healthcare and life sciences innovation, the company’s chief security officer explained how the company is evaluating the test in clinical trials and preparing to file for its FDA approval.

Leave a Reply

Your email address will not be published. Required fields are marked *